CEISTDP: Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study

Sponsor
Nova Scotia Health Authority (Other)
Overall Status
Completed
CT.gov ID
NCT01924715
Collaborator
(none)
1,082
1
14
77.5

Study Details

Study Description

Brief Summary

Objective: To evaluate whether or not cases treated with Intensive Short-term Dynamic Psychotherapy (ISTDP) facilitate healthcare cost reduction, whether any observed reduction is greater than that of a control group and whether any such gains would be maintained in follow up.

Design: A quasi-experimental design was employed in which pre and post healthcare cost and usage data were extracted for all ISTDP treated cases from 1999 to 2008 and compared to parallel measures of a control group of cases referred but never treated.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ISTDP

Detailed Description

Importance: Psychiatric and psychological disorders result in excess health care service use and costs. Brief psychotherapy methods may be effective across a broad range of mental disorders and could therefore result in healthcare cost reduction.

Objective: To evaluate whether or not cases treated with Intensive Short-term Dynamic Psychotherapy (ISTDP) facilitate healthcare cost reduction, whether any observed reduction is greater than that of a control group and whether any such gains would be maintained in follow up.

Design: A quasi-experimental design was employed in which pre and post healthcare cost and usage data were extracted for all ISTDP treated cases from 1999 to 2008 and compared to parallel measures of a control group of cases referred but never treated.

Setting: Treatments were provided at an urban University based psychotherapy service.

Participants: All cases from the province of Nova Scotia treated within the research time frame were included. 890 patients were included with a very broad range of psychiatric disorders including anxiety, mood, somatoform, personality and psychotic disorders. 192 referred but never see cases served as non randomized controls.

Intervention(s): ISTDP is an emotionally focused form of brief psychotherapy which has supportive, cognitive, experiential and primarily psychodynamic elements. In this setting the average length of treatment was 7.3 sessions and cost an estimated $500 dollars per treatment course.

Study Design

Study Type:
Observational
Actual Enrollment :
1082 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study
Study Start Date :
Jan 1, 2008
Actual Primary Completion Date :
Mar 1, 2009
Actual Study Completion Date :
Mar 1, 2009

Arms and Interventions

Arm Intervention/Treatment
ISTDP

Patients provided Intensive Short term Dynamic Psychotherapy

Behavioral: ISTDP
An emotion focused brief psychotherapy format.
Other Names:
  • Intensive Short-term Dynamic Psychotherapy
  • Control Group

    Patients referred for ISTDP but never seen for any reason

    Outcome Measures

    Primary Outcome Measures

    1. Total Doctor and Hospital Costs [1 year pre versus 3 years post]

      Total Physician and Hospital billings per patient

    Secondary Outcome Measures

    1. Hospital costs [1 year pre versus 3 years post]

      Total Hospital costs per patient

    2. Hospital Days [1 year per versus 3 years post]

      Hospital days per patient

    3. Doctor Visits [1 year pre versus 3 years post]

      Doctor Costs per patient

    4. Doctor Costs [1 year pre versus 3 years post]

      Doctor costs per patient

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All patients referred for ISTDP treatment
    Exclusion Criteria:
    • Patients not referred for ISTDP treatment

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Capital Health Halifax Nova Scotia Canada B3H 2E2

    Sponsors and Collaborators

    • Nova Scotia Health Authority

    Investigators

    • Principal Investigator: Allan A Abbass, MD, FRCPC, Nova Scotia Health Authority

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Nova Scotia Health Authority
    ClinicalTrials.gov Identifier:
    NCT01924715
    Other Study ID Numbers:
    • AA003
    First Posted:
    Aug 16, 2013
    Last Update Posted:
    Aug 16, 2013
    Last Verified:
    Jul 1, 2013

    Study Results

    No Results Posted as of Aug 16, 2013